Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1413, 2003-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Alteplase cost-effective option for acute ischaemic stroke
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 333, 2001-01 ,pp. :
Alteplase cost effective in acute MI vs streptokinase
Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. :
Disheartening results for pexelizumab in acute STEMI
Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. :
Alteplase underused in acute ischaemic stroke
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. :
Intravenous alteplase for acute ischaemic stroke
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. :